(Q36468091)

14 August 2017

Role of prostaglandins in tumour necrosis factor induced weight loss (English)

1 reference

14 August 2017

0 references

Mahony SM

1

1 reference

14 August 2017

Tisdale MJ

series ordinal

2

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 July 1989

1 reference

British Journal of Cancer

14 August 2017

1 reference

14 August 2017

60

1 reference

14 August 2017

1

1 reference

14 August 2017

51-55

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1989.218

14 August 2017

0 references

cites work

Elevated thromboxane levels in the rat during endotoxic shock: protective effects of imidazole, 13-azaprostanoic acid, or essential fatty acid deficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247348

Weight loss associated with an endotoxin-induced mediator from peritoneal macrophages: the role of cachectin (tumor necrosis factor).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247348

Comparison of weight loss induced by recombinant tumour necrosis factor with that produced by a cachexia-inducing tumour

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247348

Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247348

Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247348

Interleukin 1, tumour necrosis factor-alpha (cachectin) and the pathogenesis of cancer cachexia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247348

Induction of weight loss and metabolic alterations by human recombinant tumour necrosis factor

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247348

The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247348

Cachectin and tumour necrosis factor as two sides of the same biological coin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247348

Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247348

Identity of tumour necrosis factor and the macrophage-secreted factor cachectin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247348

Tumors secreting human TNF/cachectin induce cachexia in mice

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247348

Interleukin 1 and tumor necrosis factor do not regulate protein balance in skeletal muscle.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247348

Recombinant tumor necrosis factor and interleukin-1 both stimulate human synovial cell arachidonic acid release and phospholipid metabolism

28 June 2018

1 reference

12 December 2020

Tumor necrosis factor type alpha (cachectin) stimulates mouse osteoblast-like cells (MC3T3-E1) to produce macrophage-colony stimulating activity and prostaglandin E2

1 reference

12 December 2020

Tumor necrosis factor and interleukin-1 beta: suppression of food intake by direct action in the central nervous system

1 reference

12 December 2020

Cachectin/tumor necrosis factor: a possible mediator of cancer anorexia in the rat

1 reference

12 December 2020

Anti-tumor activity of recombinant mouse tumor necrosis factor (TNF) on colon cancer in rats is promoted by recombinant rat interferon gamma; toxicity is reduced by indomethacin

1 reference

12 December 2020

Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression

1 reference

12 December 2020

Tumor Necrosis Factor Not Detectable in Patients With Clinical Cancer Cachexia

1 reference

12 December 2020

Renal function in conscious rats after indomethacin. Evidence for a tubular action of endogenous prostaglandins

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1989.218

1 reference

Dimensions Publication ID

14 August 2017

0 references

1 reference

14 August 2017

1 reference